NIH https://www.nih.gov has launched the first phase of the Neuromod Prize a $9.8 million competition to accelerate the development of neuromodulation therapies used to adjust nerve activity to improve organ function. Phase 2 and 3 are expected to be announced at a future time.
The competition seeks scientists, engineers, and clinicians to submit novel concepts and clinical development plans to demonstrate solutions for precisely stimulating the peripheral nervous system to treat disease and improve human health.
The first phase of the competition will award up to $800,000. NIH plans to launch a second phase awarding up to $4 million, and a third phase awarding up to $5 million, subject to the availability of funds.
Neuromodulation therapies have the potential to treat a variety of health conditions by targeted regulation of the nerves that connect with all parts of the body. Recent innovations in device technology and improved understanding of the interactions between the nervous system and target tissues and organs has led to a breakthrough in the field.
Phase 1 participants will submit concept papers describing their proposed therapeutic approaches and plans for conducting proof-of-concept studies, rationales for therapeutic use, and expectations for clinical impact.
Submissions are due through an online portal by April 28, 2022. For more information, go to https://neuromodprize.com/accelerate-the-development-of-targeted-neuromodulation-therapies-submit-a-concept-by-april-28